Below is the text of the page https://www.physiogel.ua/ stored 2017-06-24 by archive.org.ua. The original page over time could change. View as original html

Home | GSK

GSK [/en-gb/] Behind the science Global Africa Back Algeria Kenya Morocco Nigeria South Africa Tunisia Asia & the Middle East Back Armenia Azerbaijan Bangladesh Cambodia China ZH EN Egypt Georgia Hong Kong EN ZH India Indonesia EN ID Israel Japan Kazakhstan Korea Malaysia Myanmar Pakistan Philippines Saudi Arabia Singapore Sri Lanka Taiwan Thailand Turkey United Arab Emirates Uzbekistan Vietnam VI EN Australasia Back Australia New Zealand Europe Back Albania Austria Belarus Belgium FR NL EN Bosnia and Herzegovina Bulgaria Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Ireland Italy Latvia Lithuania Luxembourg Macedonia Malta Moldova Netherlands Norway Poland Portugal Romania Russia Serbia Slovakia Slovenia Spain Sweden Switzerland DE FR Ukraine United Kingdom North America Back Canada EN FR Mexico United States South & Central America Back Argentina Brazil Caribbean Islands Chile Colombia Costa Rica Dominican Republic Ecuador El Salvador Guatemala Honduras Jamaica Nicaragua Panama Peru Trinidad & Tobago Uruguay Venezuela Contact us Search Menu About us Close menu About us We are a science-led global healthcare company on a mission: we want to help people do more, feel better, live longer Visit this section Back About us Visit this section What we do Back What we do Visit this section Pharmaceuticals Vaccines Consumer Healthcare Our mission and strategy Corporate Executive Team Board of Directors Our history Governance Back Governance Visit this section Board committees Other committees Shareholders Sarbanes-Oxley Act 2002 Global Ethics and Compliance Corporate partnerships Back Corporate partnerships Visit this section Save the Children partnership Comic Relief partnership Key achievements Policies, codes and standards How we create value What we do We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare Products Close menu Products We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare Visit this section Back Products Visit this section Our prescription medicines Our vaccines Our consumer healthcare products ViiV Healthcare Stiefel dermatology Our consumer healthcare products Our consumer healthcare business has a portfolio of some of the world’s most trusted and best selling products in Pain Relief, Oral health, Respiratory, Nutrition and Skin health Careers Close menu Careers Explore GSK, the people behind it and a range of opportunities to be part of an organisation that helps people around the world to do more, feel better, live longer Visit this section Back Careers Visit this section Search jobs and apply Explore our business Back Explore our business Visit this section Research and development Manufacturing and supply Sales and marketing Business support services Working at GSK Back Working at GSK Visit this section Developing our people Employee health, safety and well-being Inclusion and diversity Our culture and values Rewarding performance Graduates Back Graduates Visit this section Graduate stories - Future leaders on global assignment Postgraduates Back Postgraduates Visit this section Esprit Commercial Programme Esprit Finance Programme Esprit R&D Internship Opportunities R&D postdoctoral global training programme Immunology Catalyst postdoctoral training programme Application Process Students and apprentices Back Students and apprentices Visit this section Meet our students and apprentices Experienced professionals Meet our people Physicians Our locations Explore our business Discover the work we do and the opportunities that exist, from research and development through to making our products available to those who need them Investors Close menu Investors Information and tools for investors including share and dividend information, share price analysis, latest news and corporate reporting Visit this section Back Investors Visit this section Shareholder information Back Shareholder information Visit this section Dividend calculator (GBP) Dividend calculator (USD) Dividend calendar Manage your shares Annual General Meeting General Meeting Corporate sponsored nominee service Asset Reunification – ProSearch Share scam alert Quarterly results Corporate reporting Back Corporate reporting Visit this section Annual Report 2016 Corporate reporting archive Share price analysis Back Share price analysis Visit this section Detailed share price Share price calculator (GBP) Share price calculator (USD) Financial calendar Stock exchange announcements Back Stock exchange announcements Visit this section London (RNS) London (RNS) inside information New York (SEC) About GSK Speeches & presentations Product pipeline GSK/Novartis transaction Investors contact details Quarterly results Discover our latest financial performance announcement and search for historical quarterly results materials Media Close menu Media Explore the latest news, different ways to stay in touch and available useful resources Visit this section Back Media Visit this section Press releases Resource centre Back Resource centre Visit this section Pharmaceuticals resources Global health resources Anti-doping Bioelectronics China investigation Microbeads Paroxetine information Social media Back Social media Visit this section Twitter Facebook YouTube LinkedIn Flickr Image and video library Media contact details Press releases Keep up to date with our news and recent announcements Research Close menu Research Science can improve health and well-being in so many ways, from the development of everyday convenience healthcare products through to life-saving medicines and vaccines Visit this section Back Research Visit this section R&D locations Back R&D locations Visit this section Europe UK Asia USA & Canada What we are working on Back What we are working on Visit this section Product pipeline Antibiotics research Bioelectronics research How we discover our new products Back How we discover our new products Visit this section Our approach How we discover new medicines How we discover new vaccines Consumer healthcare research Open innovation Back Open innovation Visit this section Diseases of the developing world Non-communicable diseases in Africa Stevenage bioscience hub Targeting the immune system through open innovation Africa NCD Open Lab Trials in people Back Trials in people Visit this section Clinical trial phases Become a clinical research volunteer Independent clinical studies Sharing our research Back Sharing our research Visit this section Clinical study register Patient-level data Research funding Back Research funding Visit this section Trust in Science Africa Trust in Science LATAM Collaborative approach Our use of animals Back Our use of animals Visit this section The 3Rs in medicine research Use of non-human primates Frequently asked questions 50 years of R&D innovation 50 years of R&D innovation Learn more about our R&D legacy involving the development of a broad range of innovative medicines, vaccines and consumer healthcare products Responsibility Close menu Responsibility Responsible business is how we do business. Our mission is to improve the quality of human life by enabling people to do more, feel better, live longer Visit this section Back Responsibility Visit this section Health for all Back Health for all Visit this section Access to healthcare Tackling diseases in developing countries HIV, AIDS and ViiV Healthcare Health and well-being in communities Reinvesting in healthcare Sustainable development Our health for all commitments Our behaviour Back Our behaviour Visit this section Sales and marketing practices Research practices Ethical conduct Public policy and patient advocacy Engaging with healthcare professionals Compassionate use (Expanded access) Working with third parties Rigorous patient and consumer safety Human rights and modern slavery Our behaviour commitments Our people Back Our people Visit this section Working at GSK Employee volunteering Improving health, safety and resilience Our people commitments Our planet Back Our planet Visit this section Carbon Water Waste Environmental stewardship Our planet commitments Responsibility reports & data Back Responsibility reports & data Visit this section Reporting archive and resources Charitable grants Trade association memberships Patient group funding Health for all Our part in tackling global health challenges and our aim to extend the benefits of our products to more people Behind the science The fight against malaria About us Meet the children helped by our Save the Children partnership News GSK and MMV announce start of phase III programme of tafenoquine for Plasmodium vivax malaria 12 June 2017 Careers Alexa, who is Martyn Blakeley? 3D remodelled DNA helix structure About us We want to help people do more, feel better, live longer. Today there are still millions of people without access to basic healthcare, thousands of diseases without adequate treatments and millions more people who suffer from everyday ailments. At GSK we want to change this. Read more Press releases 21 June 2017 GSK presents positive results from Phase III revaccination study of its candidate shingles vaccine Shingrix at CDC’s Advisory Meeting 16 June 2017 GSK announces results from 10-year continuation study showing sustained disease control with Benlysta (belimumab) in SLE 12 June 2017 GSK and MMV announce positive headline phase III results showing single-dose tafenoquine reduces risk of relapse in patients with Plasmodium vivax malaria View all press releases London 1,708.50 -13.50 Share price at 16:35 LSE price updated every 15 minutes NYSE 44.29 +0.13 Share price at 16:02 NYSE price updated every 20 minutes Tweets from GSK GSK @GSK On #ArmedForcesDay we salute our employees who have spent time serving their country and are now helping patients:… twitter.com/i/web/status/8… about 3 hours ago GSK @GSK Rising health threats like Ebola need to be stopped. That’s why we’re partnering with others to form a biopreparedn… twitter.com/i/web/status/8… about 18 hours ago GSK @GSK Thanks @aspenideas for inviting our vaccines president to be a #SpotlightHealth speaker on biopreparedness this wee… twitter.com/i/web/status/8… about 18 hours ago Follow us on Twitter Find out more Our products We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare Career opportunities at GSK Discover the work we do and the opportunities that exist, from research and development through to making our products available to those who need them Health for all Our medicines, vaccines and consumer healthcare products are improving quality of life for patients and consumers around the world. GSK Sitemap Terms of use Accessibility Cookie policy Privacy Statement GSK employees Contact us Partnerships Business to business Report a possible side effect Supplier portal Modern Slavery Act statement (PDF) © 2001-2017 GlaxoSmithKline plc. All rights reserved. GlaxoSmithKline plc. Registered in England and Wales No. 3888792. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.